发明名称 Endothelin converting enzymes and the amyloid betapeptide
摘要 The invention describes catabolism of Abeta by endothelin converting enzymes (ECEs). Methods of identifying compounds that upregulate ECEs are provided by the invention. Further provided by the invention are methods of regulating Abeta catabolism in a cell and methods of decreasing the amount of Abeta in a cell. The invention discloses methods of diagnosing an individual with AD and methods of treating such an individual. The invention further discloses methods of identifying compounds that have anti-hypertension activity but do not cause an increase in the level of Abeta. Further, the invention provides mutant ECE nucleic acids and mutant ECE polypeptides.
申请公布号 AU8901801(A) 申请公布日期 2002.03.26
申请号 AU20010089018 申请日期 2001.09.13
申请人 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 发明人 CHRISTOPHER B. ECKMAN;ELIZABETH A. ECKMAN
分类号 A61P9/12;A61P25/28;C12N9/64;C12Q1/37;C12Q1/68;G01N33/68 主分类号 A61P9/12
代理机构 代理人
主权项
地址